{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:46:20Z","timestamp":1793407580843,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-005"],"award-info":[{"award-number":["2021-I2M-1-005"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-1-004"],"award-info":[{"award-number":["2022-I2M-1-004"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2023-I2M-2-005"],"award-info":[{"award-number":["2023-I2M-2-005"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ard.2025.07.018","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T20:15:24Z","timestamp":1755893724000},"page":"1733-1742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritis"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3697-6737","authenticated-orcid":false,"given":"Xiaochuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2025.07.018_bib0001","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41572-021-00327-5","article-title":"Large-vessel vasculitis","volume":"7","author":"Pugh","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ard.2025.07.018_bib0002","article-title":"Advances in Takayasu arteritis: an Asia Pacific perspective","volume":"9","author":"Danda","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"suppl 1","key":"10.1016\/j.ard.2025.07.018_bib0003","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/1756-185X.13285","article-title":"Recent advances in the management of Takayasu arteritis","volume":"22","author":"Misra","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.07.018_bib0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2025.07.018_bib0005","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of giant cell arteritis and Takayasu arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.07.018_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1515\/rir-2024-0002","article-title":"Chinese guideline for the diagnosis and treatment of Takayasu\u2019s arteritis (2023)","volume":"5","author":"Tian","year":"2024","journal-title":"Rheumatol Immunol Res"},{"key":"10.1016\/j.ard.2025.07.018_bib0007","article-title":"The efficacy of mycophenolate mofetil for the treatment of Chinese Takayasu\u2019s arteritis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ard.2025.07.018_bib0008","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.1780370420","article-title":"Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate","volume":"37","author":"Hoffman","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ard.2025.07.018_bib0009","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/ard.51.7.904","article-title":"Induction of remission in a patient with Takayasu\u2019s arteritis by low dose pulses of methotrexate","volume":"51","author":"Mevorach","year":"1992","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2025.07.018_bib0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ard.2025.07.018_bib0011","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2478\/rir-2022-0033","article-title":"RheumCloud app: a novel mobile application for the management of rheumatic diseases patients in China","volume":"3","author":"Huang","year":"2022","journal-title":"Rheumatol Immunol Res"},{"issue":"5","key":"10.1016\/j.ard.2025.07.018_bib0012","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1440-1797.2005.00444.x","article-title":"Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis","volume":"10","author":"Ong","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ard.2025.07.018_bib0013","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/S0167-5273(96)02813-6","article-title":"Angiographic findings of Takayasu arteritis: new classification","volume":"54","author":"Hata","year":"1996","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ard.2025.07.018_bib0014","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/rheumatology\/kez421","article-title":"Derivation of an angiographically based classification system in Takayasu\u2019s arteritis: an observational study from India and North America","volume":"59","author":"Goel","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ard.2025.07.018_bib0015","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/ard-2022-223482","article-title":"2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ard.2025.07.018_bib0016","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/CIRCULATIONAHA.116.027094","article-title":"Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients","volume":"136","author":"Comarmond","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ard.2025.07.018_bib0017","article-title":"Novel therapies in Takayasu arteritis","volume":"8","author":"Regola","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.ard.2025.07.018_bib0018","first-page":"127","article-title":"Chinese expert investigation on diagnosis and disease activity evaluation in Takayasu\u2019s arteritis","volume":"44","author":"Dai","year":"2017","journal-title":"Fudan Univ J Med Sci"},{"key":"10.1016\/j.ard.2025.07.018_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320922019","article-title":"Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu\u2019s arteritis: an observational study","volume":"11","author":"Dai","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.ard.2025.07.018_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20930114","article-title":"Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study","volume":"12","author":"Ying","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"7","key":"10.1016\/j.ard.2025.07.018_bib0021","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00296-017-3704-7","article-title":"The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis","volume":"37","author":"Dai","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ard.2025.07.018_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320975233","article-title":"Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis","volume":"11","author":"Wu","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.07.018_bib0023","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/mr\/roac157","article-title":"Clinical and angiographic outcomes of mycophenolate versus methotrexate in South Asian patients of Takayasu arteritis: results from an open-label, outcome-assessor blinded randomized controlled trial","volume":"34","author":"Padiyar","year":"2023","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2025.07.018_bib0024","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2017-211878","article-title":"Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)","volume":"77","author":"Nakaoka","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.07.018_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/20406223231158567","volume":"14","author":"Sun","year":"2023","journal-title":"Ther Adv Chronic Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672504289X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672504289X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:00:15Z","timestamp":1777190415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672504289X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S000349672504289X"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.07.018","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}